MSK Infection Disease physicians are central to patient care, education, research & QI -- yet many lack funding or protected time. Our new JBJI study maps MSK ID practice structures & workforce needs.
https://t.co/RrqkhuziHR
#MSKID#MSIS
How many stages are enough for PJI revision? 1, 1.5, or 2?
Don't miss the Europe vs. North America Showdown II at #EBJIS_MSIS_2026 in Porto!
🇺🇸 Ken Urish (US): Two is Better Than One
🇵🇹 Ricardo Sousa (PT): 1.5 Stage: 0.5 Too Much?
🗓️ Sept 17, 2026 | ⏰ 09:40-10:30 AM
🆕️⚡️⚡️ @OFIDJournal
Implementing oral antibiotics for bone and joint infections: Lessons learned and opportunities for improvement #idxposts https://t.co/Esp0sdGYtl
@SEdwardsPharmD I’m coming back on service the last 2 weeks of February! Get ready! Will sign off with the hashtag - #nopiccfeb- just kidding but You know I would do it if I could :)
Very excited to see our results in @OFIDJournal! The shift from trough -> AUC @uabmedicine was a huge effort involving a variety of disciplines but leveraging several aspects of Bayesian-derived monitoring simplified the process.This has been huge in improving safety for our pts!
Coccidioides Meningitis: An Unusual Presentation of a Devastating Disease | Annals of Internal Medicine: Clinical Cases great discussion from @danidelimac and @UAB_ID Team! #coccidiodes @JohnLynchID @WU_Mycoses https://t.co/m4naDlQJ0E
Linezolid & serotonin toxicity, we need more data like this one! 🆕⚡⚡@OFIDJournal
Cross-sectional analysis of linezolid in combination with methadone or buprenorphine
ZERO cases of definite serotonin toxicity & 2 cases of possible serotonin toxicity https://t.co/N1KiulKzZk
4/
BORSA is defined by borderline resistance to antistaphylococcal penicillins with an oxacillin MIC of 1-8.
But, there is no PBP2a or mecA/C present...🧐
So other mechanisms of resistance must be present.
https://t.co/a7f99AnMSV
11/
In summary:
💥 BORSA: borderline oxacillin-resistant Staph aureus
💥 Resistance mediated by beta-lactamases
💥 No mecA or PBP2a, negative cefoxitin disc
💥 Treat similar to MRSA